In May, India's Cipla voluntarily pulled a lot of its levalbuterol from the U.S. market after the asthma inhalation drug failed a test for a degradant. Shortly after, FDA inspectors visited the plant ...
NEW DELHI, (IANS) – Drug makers Cipla and Glenmark are recalling their products from the US market due to manufacturing issues. Following the latest Enforcement Report from the US Food and Drug ...
While many of India's other large drugmakers have run afoul of the FDA for plant problems, Cipla has mostly avoided such entanglements. But suddenly the company is facing some FDA issues at two plants ...
** Cipla Ltd, India's fourth-largest drugmaker by sales, closes down 2.1 pct; snaps two-day rally of 2.6 pct ** Traders cite a letter, a so-called 'form 483', the U.S. Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results